“Rising Adoption of Intravitreal Injections”
The adoption of intravitreal injections is increasingly becoming the standard for administering therapies in the treatment of Geographic Atrophy (GA). This method ensures that medications are delivered directly to the retina, allowing for localized treatment with minimal systemic exposure, which reduces the risk of adverse side effects. Advancements in injection delivery techniques, such as fine-gauge needles and optimized injection protocols, have improved the overall safety and comfort of the procedure. Additionally, innovations in sustained-release formulations are helping to reduce the frequency of injections, enhancing adherence among patients, particularly in elderly populations who may face challenges with frequent clinical visits.